(Circulation. 1998;98:1853-1859.)
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Duke Clinical Research Institute, Durham, NC (L.K.N., E.M.O., T.D.T., K.L.L., C.C., C.B.G., R.M.C.); University of Maryland Medical System, Baltimore (R.H.C.); University of Alberta, Edmonton, Alberta, Canada (P.W.A.); University Hospital of Hamburg, Germany (C.W.H.); University of Heidelberg, Germany (H.A.K.); and the Cleveland Clinic Foundation, Cleveland, Ohio (E.J.T.).
BackgroundThe baseline cardiac troponin T (cTnT) level strongly predicts short-term mortality in acute coronary syndromes, but the added value of later measures to predict short- and long-term outcome and in the context of baseline clinical characteristics is unclear.
Methods and ResultsRelations between baseline, peak, and 8- and
16-hour (late) cTnT results and outcomes were assessed in 734 patients
in a GUSTO-IIa substudy. Proportional-hazards models assessed the
prognostic information gained from late cTnT when added to a mortality
model containing the baseline cTnT result and clinical factors. At
baseline, 260 patients were cTnT-positive (>0.1 ng/mL), 323 became
positive later, and 151 remained negative (
0.1 ng/mL). Mortality at
30 days was 10% in the baseline-positive group, 5% in late-positive
patients, and 0% in negative patients. After adjustment for baseline
characteristics, any positive cTnT result predicted 30-day mortality
(baseline,
2=8.96, P=0.0113; 8-hour,
2=6.51, P=0.0107; 16-hour,
2=8.40, P=0.0038). Both the 8- and the
16-hour results added to the strength of the baseline result
(baseline+8-hour,
2=12.04, P=0.0072;
baseline+16-hour,
2=13.52, P=0.0036).
Only age and ST-segment elevation were stronger predictors of 30-day
mortality than baseline cTnT; results were similar for prediction of
1-year mortality. Most of the mortality difference between
cTnT-positive and -negative patients occurred within the first 30
days.
ConclusionsThe cTnT level is a strong, independent predictor of short-term outcome in acute coronary syndromes. The addition of later samples to a baseline level is useful to evaluate the risk of serious cardiac events.
Key Words: risk factors mortality prognosis ischemia
This article has been cited by other articles:
![]() |
J. C. Huffman, F. A. Smith, M. A. Blais, A. M. Taylor, J. L. Januzzi, and G. L. Fricchione Pre-Existing Major Depression Predicts In-Hospital Cardiac Complications After Acute Myocardial Infarction Psychosomatics, July 1, 2008; 49(4): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kavsak, A. M. Newman, D. T. Ko, G. E. Palomaki, V. Lustig, A. R. MacRae, and A. S. Jaffe Is a Pattern of Increasing Biomarker Concentrations Important for Long-Term Risk Stratification in Acute Coronary Syndrome Patients Presenting Early after the Onset of Symptoms? Clin. Chem., April 1, 2008; 54(4): 747 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J. Am. Coll. Cardiol., August 14, 2007; 50(7): e1 - e157. [Full Text] [PDF] |
||||
![]() |
R. Shah, J. Selter, Y. Wang, M. Greenspan, and J. M. Foody Association of Troponin Status With Guideline-Based Management of Acute Myocardial Infarction in Older Persons Arch Intern Med, August 13, 2007; 167(15): 1621 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Circulation, April 3, 2007; 115(13): e356 - e375. [Full Text] [PDF] |
||||
![]() |
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes Clin. Chem., April 1, 2007; 53(4): 552 - 574. [Full Text] [PDF] |
||||
![]() |
D. A. Waxman, S. Hecht, J. Schappert, and G. Husk A Model for Troponin I as a Quantitative Predictor of In-Hospital Mortality J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1755 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thielmann, P. Massoudy, M. Neuhauser, K. Tsagakis, G. Marggraf, M. Kamler, K. Mann, R. Erbel, and H. Jakob Prognostic Value of Preoperative Cardiac Troponin I in Patients Undergoing Emergency Coronary Artery Bypass Surgery With Non-ST-Elevation or ST-Elevation Acute Coronary Syndromes Circulation, July 4, 2006; 114(1_suppl): I-448 - I-453. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Babuin and A. S. Jaffe Troponin: the biomarker of choice for the detection of cardiac injury Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Ginsburg, M. P. Donahue, and L. K. Newby Prospects for Personalized Cardiovascular Medicine: The Impact of Genomics J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1615 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Roe, E. D. Peterson, Y. Li, C. V. Pollack Jr, R. H. Christenson, W. F. Peacock, F. M. Fesmire, L. K. Newby, R. L. Jesse, J. W. Hoekstra, et al. Relationship Between Risk Stratification by Cardiac Troponin Level and Adherence to Guidelines for Non-ST-Segment Elevation Acute Coronary Syndromes Arch Intern Med, September 12, 2005; 165(16): 1870 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashida, N. Kume, T. Murase, M. Minami, D. Nakagawa, T. Inada, M. Tanaka, A. Ueda, G. Kominami, H. Kambara, et al. Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis Circulation, August 9, 2005; 112(6): 812 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Gibler, C. P. Cannon, A. L. Blomkalns, D. M. Char, B. J. Drew, J. E. Hollander, A. S. Jaffe, R. L. Jesse, L. K. Newby, E. M. Ohman, et al. Practical Implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the Emergency Department: A Scientific Statement From the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers Circulation, May 24, 2005; 111(20): 2699 - 2710. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gluckman, M. Sachdev, S. P. Schulman, and R. S. Blumenthal A Simplified Approach to the Management of Non-ST-Segment Elevation Acute Coronary Syndromes JAMA, January 19, 2005; 293(3): 349 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bolognese, K. Ducci, P. Angioli, G. Falsini, F. Liistro, S. Baldassarre, and A. Burali Elevations in Troponin I After Percutaneous Coronary Interventions Are Associated With Abnormal Tissue-Level Perfusion in High-Risk Patients With Non-ST-Segment-Elevation Acute Coronary Syndromes Circulation, September 21, 2004; 110(12): 1592 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickman, J.M.A. Swinburn, and R. Senior Wall thickening assessment with tissue harmonic echocardiography results in improved risk stratification for patients with non-ST-segment elevation acute chest pain Eur J Echocardiogr, March 1, 2004; 5(2): 142 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Luepker, F. S. Apple, R. H. Christenson, R. S. Crow, S. P. Fortmann, D. Goff, R. J. Goldberg, M. M. Hand, A. S. Jaffe, D. G. Julian, et al. Case Definitions for Acute Coronary Heart Disease in Epidemiology and Clinical Research Studies: A Statement From the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute Circulation, November 18, 2003; 108(20): 2543 - 2549. [Full Text] [PDF] |
||||
![]() |
T A Hyde, J K French, C-K Wong, C Edwards, R M L Whitlock, and H D White Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes Heart, May 1, 2003; 89(5): 490 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Holmvang, P. Clemmensen, B. Lindahl, B. Lagerqvist, P. Venge, G. Wagner, L. Wallentin, and P. Grande Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment J. Am. Coll. Cardiol., March 19, 2003; 41(6): 905 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
P O Collinson, P J Stubbs, and A-C Kessler Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice Heart, March 1, 2003; 89(3): 280 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bholasingh, J. H. Cornel, O. Kamp, J. P. van Straalen, G. T. Sanders, J. G. P. Tijssen, V. A. W. M. Umans, C. A. Visser, and R. J. de Winter Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T J. Am. Coll. Cardiol., February 19, 2003; 41(4): 596 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Newby, B. U. Goldmann, and E. M. Ohman Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromes J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 31S - 36S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.M Califf Cardiac markers in acute coronary syndromes--refining our knowledge Eur. Heart J., January 2, 2003; 24(2): 136 - 137. [Full Text] [PDF] |
||||
![]() |
L.K Newby, M.V Bhapkar, H.D White, E.J Topol, F.C Dougherty, R.A Harrington, M.C Smith, L.F Asarch, R.M Califf, and for the SYMPHONY and 2nd SYMPHONY Investigators Predictors of 90-day outcome in patients stabilized after acute coronary syndromes Eur. Heart J., January 2, 2003; 24(2): 172 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Udelson, J. R. Beshansky, D. S. Ballin, J. A. Feldman, J. L. Griffith, G. V. Heller, R. C. Hendel, J. H. Pope, R. Ruthazer, E. J. Spiegler, et al. Myocardial Perfusion Imaging for Evaluation and Triage of Patients With Suspected Acute Cardiac Ischemia: A Randomized Controlled Trial JAMA, December 4, 2002; 288(21): 2693 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Apple, M. M. Murakami, R. L. Jesse, M. A. Levitt, A. K. Berger, L. A. Pearce, and P. Collinson Near-Bedside Whole-Blood Cardiac Troponin I Assay for Risk Assessment of Patients with Acute Coronary Syndromes Clin. Chem., October 1, 2002; 48(10): 1784 - 1787. [Full Text] [PDF] |
||||
![]() |
T. Jernberg, M. Stridsberg, P. Venge, and B. Lindahl N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation J. Am. Coll. Cardiol., August 7, 2002; 40(3): 437 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Meier, W. H. Al-Badr, J. V. Cooper, E. M. Kline-Rogers, D. E. Smith, K. A. Eagle, and R. H. Mehta The New Definition of Myocardial Infarction: Diagnostic and Prognostic Implications in Patients With Acute Coronary Syndromes Arch Intern Med, July 22, 2002; 162(14): 1585 - 1589. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Wong, D. A. Morrow, S. Murphy, N. Kraimer, R. Pai, D. James, D. H. Robertson, L. A. Demopoulos, P. DiBattiste, C. P. Cannon, et al. Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy Circulation, July 9, 2002; 106(2): 202 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Olukoga and D. Donaldson An overview of biochemical markers in acute coronary syndromes The Journal of the Royal Society for the Promotion of Health, June 1, 2001; 121(2): 102 - 106. [Abstract] [PDF] |
||||
![]() |
D. Fitchett, S. Goodman, and A. Langer New advances in the management of acute coronary syndromes: 1. Matching treatment to risk Can. Med. Assoc. J., May 1, 2001; 164(9): 1309 - 1316. [Full Text] [PDF] |
||||
![]() |
L. K. Newby, A. B. Storrow, W. B. Gibler, J. L. Garvey, J. F. Tucker, A. L. Kaplan, D. H. Schreiber, R. H. Tuttle, S. E. McNulty, and E. M. Ohman Bedside Multimarker Testing for Risk Stratification in Chest Pain Units : The Chest Pain Evaluation by Creatine Kinase-MB, Myoglobin, and Troponin I (CHECKMATE) Study Circulation, April 10, 2001; 103(14): 1832 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Christenson, S. H. Duh, F. S. Apple, G. S. Bodor, D. M. Bunk, J. Dalluge, M. Panteghini, J. D. Potter, M. J. Welch, A. H.B. Wu, et al. Standardization of Cardiac Troponin I Assays: Round Robin of Ten Candidate Reference Materials Clin. Chem., March 1, 2001; 47(3): 431 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Christenson, S. H. Duh, W. R. Sanhai, A. H.B. Wu, V. Holtman, P. Painter, E. Branham, F. S. Apple, M. Murakami, and D. L. Morris Characteristics of an Albumin Cobalt Binding Test for Assessment of Acute Coronary Syndrome Patients: A Multicenter Study Clin. Chem., March 1, 2001; 47(3): 464 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dixit, M. Castle, R. P. Velu, L. Swisher, C. Hodge, and A. S. Jaffe Cardiac Involvement in Patients With Acute Neurologic Disease: Confirmation With Cardiac Troponin I Arch Intern Med, November 13, 2000; 160(20): 3153 - 3158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Matetzky, T. Sharir, M. Domingo, M. Noc, K.-Y. Chyu, S. Kaul, N. Eigler, P. K. Shah, and B. Cercek Elevated Troponin I Level on Admission Is Associated With Adverse Outcome of Primary Angioplasty in Acute Myocardial Infarction Circulation, October 3, 2000; 102(14): 1611 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Bhatt and E. J. Topol Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes JAMA, September 27, 2000; 284(12): 1549 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sonel, B. M. Sasseen, N. Fineberg, N. Bang, and R. L. Wilensky Prospective Study Correlating Fibrinopeptide A, Troponin I, Myoglobin, and Myosin Light Chain Levels With Early and Late Ischemic Events in Consecutive Patients Presenting to the Emergency Department With Chest Pain Circulation, September 5, 2000; 102(10): 1107 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Braunwald, E. M. Antman, J. W. Beasley, R. M. Califf, M. D. Cheitlin, J. S. Hochman, R. H. Jones, D. Kereiakes, J. Kupersmith, T. N. Levin, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-st-segment elevation myocardial infarction: A report of the american college of cardiology/ american heart association task force on practice guidelines (committee on the management of patients with unstable angina) J. Am. Coll. Cardiol., September 1, 2000; 36(3): 970 - 1062. [Full Text] [PDF] |
||||
![]() |
T Jernberg, B Lindahl, and L Wallentin The combination of a continuous 12-lead ECG and troponin T. A valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG Eur. Heart J., September 1, 2000; 21(17): 1464 - 1472. [Abstract] [PDF] |
||||
![]() |
L.K. Newby and E.M. Ohman Troponins in pericarditis: implications for diagnosis and management of chest pains patients Eur. Heart J., May 2, 2000; 21(10): 798 - 800. [PDF] |
||||
![]() |
Y. Chen, R. C. Serfass, S. M. Mackey-Bojack, K. L. Kelly, J. L. Titus, and F. S. Apple Cardiac troponin T alterations in myocardium and serum of rats after stressful, prolonged intense exercise J Appl Physiol, May 1, 2000; 88(5): 1749 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Lee and L. Goldman Evaluation of the Patient with Acute Chest Pain N. Engl. J. Med., April 20, 2000; 342(16): 1187 - 1195. [Full Text] [PDF] |
||||
![]() |
P Abrahamsson, A Rosengren, and M Dellborg Improved long-term prognosis for patients with unstable coronary syndromes 1988-1995 Eur. Heart J., April 1, 2000; 21(7): 533 - 539. [Abstract] [PDF] |
||||
![]() |
J. Ravkilde Risk Stratification in Acute Coronary Syndrome Using Cardiac Troponin I Clin. Chem., April 1, 2000; 46(4): 443 - 444. [Full Text] [PDF] |
||||
![]() |
K. Thygesen and J. Ravkilde Triage of chest pain patients based on early risk stratification using sensitive cardiac markers Eur. Heart J., March 1, 2000; 21(5): 347 - 348. [PDF] |
||||
![]() |
A. Timmis Coronary disease: Acute coronary syndromes: risk stratification Heart, February 1, 2000; 83(2): 241 - 246. [Full Text] |
||||
![]() |
S. Fuchs, R. Kornowski, R. Mehran, L. F. Satler, A. D. Pichard, K. M. Kent, M. K. Hong, S. Slack, G. W. Stone, and M. B. Leon Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes: The potential role of early percutaneous revascularization J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1704 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H.B. Wu, F. S. Apple, W. B. Gibler, R. L. Jesse, M. M. Warshaw, and R. Valdes Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: Recommendations for the Use of Cardiac Markers in Coronary Artery Diseases Clin. Chem., July 1, 1999; 45(7): 1104 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
Serial Troponin Measurement Best for Risk Stratification. Journal Watch Cardiology, December 11, 1998; 1998(1211): 1 - 1. [Full Text] |
||||
![]() |
Serial Troponin T Value Improves Coronary Risk Stratification Journal Watch (General), November 13, 1998; 1998(1113): 5 - 5. [Full Text] |
||||
![]() |
R. Roberts and R. E. Fromm Management of Acute Coronary Syndromes Based on Risk Stratification by Biochemical Markers : An Idea Whose Time Has Come Circulation, November 3, 1998; 98(18): 1831 - 1833. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |